arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2025 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Cholesterol-lowering therapy: what's new?

    THERAPY FROM A CRITICAL VIEWPOINT

    Evolocumab (REPATHA) without previous myocardial infarction or stroke?

    Fish oil: do dialysis patients have a cardiovascular benefit?

    a-t READERS QUESTIONS AND COMMENTS

    On the benefit of oseltamivir (e.g. TAMIFLU)

    Vaccinate against dementia with the herpes zoster vaccine SHINGRIX?

    IN BRIEF

    Billions in savings with biosimilars?

    SUVs – particularly dangerous for pedestrians

    SIDE EFFECTS

    Once again: men treated with valproate (ERGENYL, generics) and developmental disorders in children

    Caution: excessive iodine intake as a reslt of the consumption of algae products
    free

    Progestogen coil JAYDESS: once again more extrauterine pregnancies

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!